NCT03885817

Brief Summary

This randomized controlled trial aims to investigate whether an individually tailored exercise program and nutritional guide can affect the development of self-reported peripheral sensory neuropathy and fatigue in patients with colorectal cancer receiving adjuvant chemotherapy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Mar 2019Jun 2027

First Submitted

Initial submission to the registry

February 6, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 22, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

March 27, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2022

Completed
4.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Expected
Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

3.5 years

First QC Date

February 6, 2019

Last Update Submit

June 4, 2025

Conditions

Keywords

Exercise therapyFatigueAdjuvant chemotherapyPeripheral neuropathy, chemotherapy inducedNutritional guide

Outcome Measures

Primary Outcomes (1)

  • Patient reported peripheral sensory neuropathy

    The 9-item European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) Chemotherapy Induced Peripheral Neuropathy (CIPN20) sensory subscale will be used to measure sensory neuropathy. Each item is rated on a scale from 1 ("not at all") to 4 ("very much"), and the total raw score ranges from 9 to 36. The raw scores will be linearly transformed to a 0 to 100 scale (higher scores represent worse CIPN severity).

    Baseline to 3 months

Secondary Outcomes (27)

  • Fatigue

    Baseline to 3, 6, 9, 12, 24 and 36 months

  • Change in patient reported peripheral sensory neuropathy.

    Baseline to 3, 6, 9, 12, 24 and 36 months

  • Change in patient reported motor neuropathy

    Baseline to 3, 6, 9, 12, 24 and 36 months

  • Change in patient reported autonomic neuropathy

    Baseline to 3, 6, 9, 12, 24 and 36 months

  • Clinicians reported neuropathy

    Baseline to 3, 6 and 12 months.

  • +22 more secondary outcomes

Other Outcomes (4)

  • Serious adverse events (SAE)

    Baseline to 6 months

  • Patient's expectations and experiences

    Baseline, 3 and 6 months

  • Medical treatment for hypertension.

    Baseline, 3, 6 and 12 months

  • +1 more other outcomes

Study Arms (2)

Exercise training and nutritional guide

EXPERIMENTAL

Standard recommendations regarding physical activity and nutrition. An individually tailored exercise program and nutritional guide during adjuvant chemotherapy.

Behavioral: Exercise training and nutritional guideOther: Standard follow-up care

Standard follow-up care

ACTIVE COMPARATOR

Standard recommendations regarding physical activity and nutrition.

Other: Standard follow-up care

Interventions

30 minutes of a combination of sensorimotor- and strength training guided by a physical therapist twice a week. In addition 90 minutes a week of moderate intensity aerobic training or 45 minutes a week of high intensity aerobic training. Once a month the participants will fill out the form, PG-SGA SF, and he or she will be referred to a nutritionist if the score is 2 or higher. The intervention period lasts as long as the participants receives adjuvant chemotherapy, i.e. 3 - 6 months.

Exercise training and nutritional guide

standard recommendations regarding physical activity and nutrition during the period with adjuvant chemotherapy.

Exercise training and nutritional guideStandard follow-up care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Radical resection for colon- or rectal cancer past 3 months, and scheduled for adjuvant, Oxaliplatin-based, combination chemotherapy.
  • Histologically confirmed adenocarcinoma.
  • Able to read and understand Norwegian.
  • Able to carry out the intervention.
  • Performance Status (PS) 0 - 2.

You may not qualify if:

  • Serious comorbidities that contraindicate physical exercise, based on the treating physician's assessment.
  • Unable to give informed consent.
  • Prior treatment with Oxaliplatin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Ålesund sjukehus

Ålesund, Norway

Location

Sørlandet sykehus, Kristiansand

Kristiansand, Norway

Location

Levanger sykehus

Levanger, Norway

Location

Ullevål

Oslo, Norway

Location

Kreftklinikken, St Olavs Hospital

Trondheim, Norway

Location

Related Publications (1)

  • Hatlevoll I, Oldervoll LM, Wibe A, Stene GB, Stafne SN, Hofsli E. Physical exercise during adjuvant chemotherapy for colorectal cancer-a non-randomized feasibility study. Support Care Cancer. 2021 Jun;29(6):2993-3008. doi: 10.1007/s00520-020-05789-z. Epub 2020 Oct 8.

MeSH Terms

Conditions

Colorectal NeoplasmsFatiguePeripheral Nervous System Diseases

Interventions

Exercise

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Arne Solberg, md phd

    St. Olavs Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2019

First Posted

March 22, 2019

Study Start

March 27, 2019

Primary Completion

September 13, 2022

Study Completion (Estimated)

June 1, 2027

Last Updated

June 5, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations